NovoCure Ltd — Director's Dealing 2017

Nov 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-11-02

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-02	Ordinary Shares	S	300	$22.00	Disposed	24987	Direct
2017-11-03	Ordinary Shares	S	900	$22.00	Disposed	24087	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.